Search research articles
Contact Us
Filters
Showing results (951-960 of 1,198) with videos related to
Page
of 120
Sort By:
Molecular Biology of the Cell
|
February 18, 2026
Engineered interfaces in Rac1 and Cdc42 biosensors enhance sensitivity and reduce cell perturbation
Daniel J Marston, Ellen C O'Shaughnessy, Timothy M Jacobs, et al.
Urology
|
February 13, 2018
Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method
Heather J Chalfin, Max Kates, Emma E van der Toom, et al.
Investigational New Drugs
|
May 26, 2010
A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC)
Michael R Harrison, Noah M Hahn, Roberto Pili, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2011
Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75
Noah M Hahn, Walter M Stadler, Robin T Zon, et al.
Plos One
|
March 2, 2013
Elevated phospholipase A2 activities in plasma samples from multiple cancers
Hui Cai, Elena G Chiorean, Michael V Chiorean, et al.
Critical Care Medicine
|
March 1, 1980
The effect of newer antiarrhythmic drugs on defibrillation threshold
W A Tacker, M J Niebauer, C F Babbs, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 31, 2007
Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome
Sydney M Evans, Kevin L Du, Ara A Chalian, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 13, 2017
A prospective study of proton reirradiation for recurrent and secondary soft tissue sarcoma
David M Guttmann, Melissa A Frick, Ruben Carmona, et al.
Molecular Carcinogenesis
|
October 13, 2007
DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms
Kevin D Healy, Louis Hodgson, Tai-Young Kim, et al.
European Journal of Medical Research
|
August 12, 2009
The Patient Cohort of the German Competence Network for HIV/AIDS (KompNet): a profile
K Jansen, C Michalik, M Hahn, et al.
Page
of 120
Search research articles
Search
Showing results (951-960 of 1,198) with videos related to
Sort By:
Page
of 120
Molecular Biology of the Cell
|
February 18, 2026
Engineered interfaces in Rac1 and Cdc42 biosensors enhance sensitivity and reduce cell perturbation
Daniel J Marston, Ellen C O'Shaughnessy, Timothy M Jacobs, et al.
Urology
|
February 13, 2018
Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method
Heather J Chalfin, Max Kates, Emma E van der Toom, et al.
Investigational New Drugs
|
May 26, 2010
A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC)
Michael R Harrison, Noah M Hahn, Roberto Pili, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2011
Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75
Noah M Hahn, Walter M Stadler, Robin T Zon, et al.
Plos One
|
March 2, 2013
Elevated phospholipase A2 activities in plasma samples from multiple cancers
Hui Cai, Elena G Chiorean, Michael V Chiorean, et al.
Critical Care Medicine
|
March 1, 1980
The effect of newer antiarrhythmic drugs on defibrillation threshold
W A Tacker, M J Niebauer, C F Babbs, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 31, 2007
Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome
Sydney M Evans, Kevin L Du, Ara A Chalian, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 13, 2017
A prospective study of proton reirradiation for recurrent and secondary soft tissue sarcoma
David M Guttmann, Melissa A Frick, Ruben Carmona, et al.
Molecular Carcinogenesis
|
October 13, 2007
DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms
Kevin D Healy, Louis Hodgson, Tai-Young Kim, et al.
European Journal of Medical Research
|
August 12, 2009
The Patient Cohort of the German Competence Network for HIV/AIDS (KompNet): a profile
K Jansen, C Michalik, M Hahn, et al.
Page
of 120